Back to HALO
VANGUARD PORTFOLIO MANAGEMENT LLC → HALO
VANGUARD PORTFOLIO MANAGEMENT LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
3
Latest value
$550.6M
Q3 2026
Peak value
$550.6M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $339.3M |
| Q2 2026 | $414.8M |
| Q3 2026 | $550.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $550.6M | 4.99M | — | — |
| Q2 2026 | $414.8M | 5.30M | — | — |
| Q1 2026 | $339.3M | 5.25M | — | — |
Other funds holding HALO
$915.4M
$649.5M
$559M
$545.3M
$539.3M
$531.8M